Literature DB >> 20150543

Quality-adjusted life expectancy (QALE) and loss of QALE for patients with ischemic stroke and intracerebral hemorrhage: a 13-year follow-up.

Hsin-Yi Lee1, Jing-Shiang Hwang, Jiann-Shing Jeng, Jung-Der Wang.   

Abstract

BACKGROUND AND
PURPOSE: Few studies have evaluated the long-term health impact of stroke as categorized into different subtypes. The aim of this study is to quantify the loss of quality-adjusted life expectancy related to ischemic stroke and intracerebral hemorrhage.
METHODS: The hospital-based cohort, which consisted of 13,194 patients with first-ever stroke onset dates between 1995 and 2007, was classified into lacunar and nonlacunar infarctions and intracerebral hemorrhages. After linking with the National Mortality Registry, survival functions were determined and extrapolated over a 50-year period based on the survival ratio between the patients' survival and age- and sex-matched reference population's as calculated from the vital statistics of Taiwan. The survival functions were then multiplied by the quality of life assessed under the EuroQol 5-dimension (EQ-5D) questionnaire based on a sample of 486 patients with stroke.
RESULTS: The quality-adjusted life expectancy for a patient with ischemic stroke was 8.7 quality-adjusted life-years with an average loss of 8.3 quality-adjusted life-years, and there appeared to be no difference between lacunar and nonlacunar infarctions. Patients with intracerebral hemorrhage had a similar quality-adjusted life expectancy as those with ischemic stroke but with a significantly greater loss relative to the reference population (14.1 quality-adjusted life-years) because of younger ages.
CONCLUSION: The lifelong health burden due to stroke was approximately 9.5 quality-adjusted life-years and should be considered in future cost-effectiveness analyses for prevention.

Entities:  

Mesh:

Year:  2010        PMID: 20150543     DOI: 10.1161/STROKEAHA.109.573543

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  35 in total

1.  Impact of depression on quality-adjusted life expectancy (QALE) directly as well as indirectly through suicide.

Authors:  Haomiao Jia; Matthew M Zack; William W Thompson; Alex E Crosby; Irving I Gottesman
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2015-02-07       Impact factor: 4.328

2.  Progenitor cells as remote "bioreactors": neuroprotection via modulation of the systemic inflammatory response.

Authors:  Peter A Walker; Phillip A Letourneau; Supinder Bedi; Shinil K Shah; Fernando Jimenez; Charles S Cox
Journal:  World J Stem Cells       Date:  2011-02-26       Impact factor: 5.326

3.  Impact of nine chronic conditions for US adults aged 65 years and older: an application of a hybrid estimator of quality-adjusted life years throughout remainder of lifetime.

Authors:  Haomiao Jia; Erica I Lubetkin
Journal:  Qual Life Res       Date:  2016-01-18       Impact factor: 4.147

4.  Progenitor cell therapy for the treatment of central nervous system injury: a review of the state of current clinical trials.

Authors:  Peter A Walker; Matthew T Harting; Shinil K Shah; Mary-Clare Day; Ramy El Khoury; Sean I Savitz; James Baumgartner; Charles S Cox
Journal:  Stem Cells Int       Date:  2010-07-20       Impact factor: 5.443

5.  Utilization of emergency medical service increases chance of thrombolytic therapy in patients with acute ischemic stroke.

Authors:  Ming-Ju Hsieh; Sung-Chun Tang; Wen-Chu Chiang; Kuang-Yu Huang; Anna Marie Chang; Patrick Chow-In Ko; Li-Kai Tsai; Jiann-Shing Jeng; Matthew Huei-Ming Ma
Journal:  J Formos Med Assoc       Date:  2013-12-02       Impact factor: 3.282

6.  Integrating health-related quality of life with sickness leave days for return-to-work assessment in traumatic limb injuries.

Authors:  Wen-Hsuan Hou; Huey-Wen Liang; Ching-Lin Hsieh; Ching-Fan Sheu; Jing-Shiang Hwang; Hung-Yi Chuang
Journal:  Qual Life Res       Date:  2013-02-08       Impact factor: 4.147

7.  The predicted lifetime costs and health consequences of calcium and vitamin D supplementation for fracture prevention-the impact of cardiovascular effects.

Authors:  G Hagen; T Wisløff; I S Kristiansen
Journal:  Osteoporos Int       Date:  2016-02-04       Impact factor: 4.507

8.  Association of Intracranial Hemorrhage Risk With Non-Vitamin K Antagonist Oral Anticoagulant Use vs Aspirin Use: A Systematic Review and Meta-analysis.

Authors:  Wen-Yi Huang; Daniel E Singer; Yi-Ling Wu; Chern-En Chiang; Hsu-Huei Weng; Meng Lee; Bruce Ovbiagele
Journal:  JAMA Neurol       Date:  2018-12-01       Impact factor: 18.302

9.  Social and economic costs and health-related quality of life in stroke survivors in the Canary Islands, Spain.

Authors:  Julio Lopez-Bastida; Juan Oliva Moreno; Melany Worbes Cerezo; Lilisbeth Perestelo Perez; Pedro Serrano-Aguilar; Fernando Montón-Álvarez
Journal:  BMC Health Serv Res       Date:  2012-09-12       Impact factor: 2.655

10.  Optimal Intervals of Ultrasonography Screening for Early Diagnosis of Hepatocellular Carcinoma in Taiwan.

Authors:  Shih-Chiang Kuo; Chia-Ni Lin; Yih-Jyh Lin; Wei-Ying Chen; Jing-Shiang Hwang; Jung-Der Wang
Journal:  JAMA Netw Open       Date:  2021-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.